ClinicalTrials.Veeva

Menu

CardioSafe+: A Platform for Telerehabilitation and Monitoring of Patients With Heart Problems

U

University of Salamanca

Status

Enrolling

Conditions

Cardiovascular Diseases

Treatments

Other: Home-based exercises

Study type

Interventional

Funder types

Other

Identifiers

NCT05865158
CardioSafe+

Details and patient eligibility

About

The use of telerehabilitation seems to be effective in managing complications after suffering a cardiovascular pathology. The use of the CardioSafe+ digital platform is suggested for the management of these complications. For this reason, an intervention will be carried out to determine the effectiveness of this platform. A total of 60 participants will be recruited to carry out a home-exercise intervention through CardioSafe+ for 6 weeks. Maximun respiratory pressures, exertion capacity, and subjective sensation of exertion will be assessed.

Full description

This intervention seeks to determine the effectiveness of the CardioSafe+ digital platform in aiding individuals recovering from cardiovascular pathologies. By involving a group of 60 participants in a structured six-week home-exercise program using the CardioSafe+ platform, the objective is to measure and evaluate various factors related to their physical well-being and recovery.

Key components to be evaluated include:

Maximal Respiratory Pressures: This involves measuring the maximum force generated during inspiration and expiration, which can indicate respiratory muscle strength and function.

Exertion Capacity: The assessment aims to gauge the participants' ability to engage in physical activities, potentially reflecting improvements in overall cardiovascular fitness and endurance.

Subjective Sensation of Exertion: This component involves understanding how the participants perceive and rate their own exertion during exercises, contributing to insights about their subjective experience and effort perception.

The intervention's objective is to collect data on these parameters before and after the six-week exercise program utilizing the CardioSafe+ digital platform. This data will help determine the effectiveness of the platform in aiding individuals recovering from cardiovascular pathologies and could provide valuable insights for further implementing tele-rehabilitation in managing such health complications.

Enrollment

60 estimated patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • People who present a cardiovascular pathology with more than one year of evolution.
  • To be in a stable medical situation.
  • To have access to technological resources and knowledge for their use.

Exclusion criteria

  • People who present any contraindication established for carrying out physical activity.
  • People who present insufficient capacity to understand and obey the instructions offered by the researchers, both in the evaluation and in the intervention.
  • People who have a cardiac pathology with obvious fluctuations in the course of the disease.
  • The presence of an acute episode of the disease during the intervention period.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

Institionalized group
Experimental group
Description:
Group of institutionalized people with chronic cardiovascular diseases.
Treatment:
Other: Home-based exercises
Community-dwelling group
Experimental group
Description:
Group of community-dwelling people with chronic cardiovascular diseases.
Treatment:
Other: Home-based exercises

Trial contacts and locations

1

Loading...

Central trial contact

Beatriz María Bermejo Gil, Dr; Fátima Pérez Robledo

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems